Further analysis using Cytoscape’s MetScape plugin revealed four significantly impacted targets—PTGS2, AKT1, SRC, and MPO—which may play crucial roles in KPF’s therapeutic effects against T1DM (Figure 3D). This evidence concerns the gene AKT1 and type 1 diabetes mellitus.